In 2016, the World Health Organization published a new handbook on the classification of tumours of the brain and spinal cord. This blog takes a look at some of the changes in the way we classify tumours, given advancements in molecular testing.
In the second blog of our new series Understanding Evidence, Iain Chalmers, the founding director of Cochrane UK, looks at developments in research on prenatal corticosteroids since the work which gave rise to the Cochrane logo. Join in the conversation on Twitter @iainchalmersTTi @CochraneUK #understandingevidence
Videos of the plenary talks from the recent Cochrane colloquium are available online. Alice has had a look at some of the key points raised in the first session.
There are over 100 diseases that the National Screening Committee in the UK considers screening for – but only a fraction of these are approved for one reason or another. This blog hopes to give an introduction to the issues with screening programmes, in particular those involved in detecting cancer.
In recent years, especially due to the large scale efforts of the WHO, along with multiple stakeholders including the governments of the affected nations, the Neglected Tropical Diseases (NTDs) have come under global spotlight. In January 2013, the WHO published the “Sustaining the drive to overcome the global impact of neglected tropical diseases: second WHO report on neglected tropical diseases”1 which charted the progress achieved in the fight against NTDs.